Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
about
Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.The Role of cccDNA in HBV Maintenance.Detection of HBV Covalently Closed Circular DNAImmune Tolerant Chronic Hepatitis B: The Unrecognized RisksIn Silico Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein.Liver Monocytes and Kupffer Cells Remain Transcriptionally Distinct during Chronic Viral InfectionRestrictive influence of SAMHD1 on Hepatitis B Virus life cycle.HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection.The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde.Expression of Interferon Effector Gene SART1 Correlates with Interferon Treatment Response against Hepatitis B Infection.Transforming growth factor β-activated kinase 1 transcriptionally suppresses hepatitis B virus replication.Control of Hepatitis B Virus by CytokinesSecreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro.Host-virus interactions in hepatitis B and hepatitis C infection.Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA.Treatment of hepatitis B virus: an update.Novel targets for hepatitis B virus therapy.The role of liver sinusoidal cells in local hepatic immune surveillance.Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection.Epigenetic Regulation of Hepatitis B Virus Covalently Closed Circular DNA: Implications for Epigenetic Therapy against Chronic Hepatitis B.Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages.Analyses of HBV cccDNA Quantification and Modification.Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.Hepatitis B virus and inhibitor of apoptosis proteins - a vulnerable liaison.New horizon for radical cure of chronic hepatitis B virus infection.In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy.IFN-α-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection.HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways.Immunopathogenesis of Hepatitis B Virus.The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans.Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?Tumor necrosis factor: The key to hepatitis B viral clearance.Advanced Strategies for Eliminating the cccDNA of HBV.Global strategies are required to cure and eliminate HBV infection.HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice.Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.CTLA‑4 interferes with the HBV‑specific T cell immune response (Review).Long-Term Follow-Up of Acute Hepatitis B: New Insights in Its Natural History and Implications for Antiviral TreatmentHepatitis B virus-persistent infection and innate immunity defect: Cell-related or virus-related?
P2860
Q30854409-6E34BA7B-2181-41F3-8998-EE1A6A91C2ACQ32182914-070BDA8D-496B-4C3D-9467-35413ECAECCCQ32183310-01C32611-25F8-4141-B802-53D574E0743FQ33753902-B3B26D60-4D61-4AC7-94C2-7BFF3827D4AEQ33753964-0711ADDA-FCAF-48D3-97E0-440C4CDCB0F4Q36182295-6514A601-384F-4B17-8CC5-1080D8855CBAQ36941510-350D4BA0-C3B3-4F2D-8478-626CE3A2B3E9Q37529062-BA57DB16-DD44-42E6-A239-E466F74D7662Q37538505-64556754-ACB4-42C6-8C6F-24FFA21C64B3Q37547706-DE46D768-2FA8-4D9D-B48E-76F5FBDC991BQ37550327-DAB8CF8A-EC8B-4EFE-A202-CC8210141A96Q37628224-47C8C029-62CD-4FD3-A9E9-1DF752992AB0Q37711751-D71DE5C0-6644-49EC-967E-CF786DC4671CQ38740771-F4538AF8-FCBC-4616-933C-E8D60CBD5799Q38769680-F83507D1-9E50-46F5-A740-12996157B70BQ38794446-B5979CEA-7C6C-46AA-8503-D9A59CF01AFAQ39067316-DCEE17B9-4AA0-4F1C-A29C-4D77CB65E568Q39089948-B2DF365F-B5AF-442F-89D6-160E4DA95987Q39388118-9864E3FE-474B-409B-B9F7-182253025862Q40073818-94ACEB03-57F1-42B0-BF7B-EEE64913614EQ40089302-A76BDDFF-BC13-4B70-8940-5A9F88F31781Q40139996-02C80067-A2F9-44E7-BB31-93CDFB40F3D1Q40409391-8A1D94C2-D38C-417F-9223-E141CA55A421Q40505022-94BC3535-7DE0-48F6-8AF6-C6FE46D7368EQ40566551-70E57735-4954-4081-9866-49B64C494333Q40593364-84F6EBB8-6F9F-4E72-BA2F-76A78628B3A1Q41919495-BF83199A-DCF1-4184-9862-92819C631DD1Q41923245-0DE61876-3AD5-4164-9799-AEC44069C1FBQ41930702-13589A2B-A19F-4A82-8408-EA6C4F566E34Q45324580-96B71360-62A6-42D1-8880-E294F53F237BQ47131005-0A676CED-3A0D-4A99-9D7C-F39CB18F2BB1Q47136128-A3AF0A76-B5A4-493A-9F57-8D7F5E771467Q47548536-B7526C25-CA4F-4D4A-A162-2FA84F7B0826Q47574790-3DC4BB9C-4E48-4113-8DB8-80D98932620AQ48860247-83E074FE-C885-4ECA-9053-10494CC04FD9Q52598005-3AB51090-5C0A-4EFC-89BD-EDAAF2A371A9Q52620810-4B973F49-6E55-4D91-8E50-125E6D3B59AEQ55472983-25669B07-9C45-466F-B27D-1E5B499BDC4AQ56913083-036F78DC-FFA4-4FE4-8424-83FD6E18777DQ57160343-B40E137A-125B-4D63-B015-627DDE0E4B50
P2860
Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Interferon-γ and Tumor Necrosi ...... rm, cccDNA, Without Cytolysis.
@en
type
label
Interferon-γ and Tumor Necrosi ...... rm, cccDNA, Without Cytolysis.
@en
prefLabel
Interferon-γ and Tumor Necrosi ...... rm, cccDNA, Without Cytolysis.
@en
P2093
P50
P1433
P1476
Interferon-γ and Tumor Necrosi ...... orm, cccDNA, Without Cytolysis
@en
P2093
Antje Malo
Christine S Falk
Daniela Stadler
Dennis Webb
Dieter Hoffmann
Felix Bohne
Florian Reisinger
Marianna Hösel
Mathias Heikenwalder
P304
P356
10.1053/J.GASTRO.2015.09.026
P407
P50
P577
2015-09-28T00:00:00Z